Immunaeon Inc. — Form D
Immunaeon Inc. of BUFFALO, NY, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-04. $250K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-04-04
- Form: D
- Accession: 0001971360-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $250K
- Minimum investment: $5K
- Investors: 1
- Date of first sale: 2023-02-23
- Revenue range: $1 - $1,000,000
- SEC file number: 021-477830
Issuer
- Name: Immunaeon Inc.
- CIK: 0001971360
- Entity type: Corporation
- Jurisdiction: NEW YORK
- Incorporated: 2018
- Address: 701 ELLICOTT STREET, BUFFALO, NY, 14203
- Phone: 716-336-6543
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Joseph Dinardo | Executive Officer | Boston, MA |
| Daniel Rera | Executive Officer | Orchard Park, NY |
| Adam Utley | Executive Officer | Buffalo, NY |
More